A5DQN2 AF NFT

Potential protein lysine methyltransferase SET5

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeiciojdczhrpd2fsp4jp63x4n6c7tgidcrwhxo27uzkkifibqfqd6i/metadata.json
IPFS of structure file: 
bafybeib2cr7bwlakkqwhxa3gvi3yhs5ete7nhqwwsghpb7gy6g53rlb4bu/AF-A5DQN2-F1-model_v2.pdb
First NFT owner address (eip-55): 
0xa73BAb1DabE4333A884D03393eAa10c3B4215494
First NFT owner address (bech32): 
genesis15ua6k8dtusen4zzdqvuna2sscw6zz4y5hahjw0
Current NFT ID #426842 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
426842
Accession (UniProt):
A5DQN2
Name::
Potential protein lysine methyltransferase SET5
Experimental Method:
Predicted structure
Sequence source:
Meyerozyma guilliermondii (strain ATCC 6260 / CBS 566 / DSM 6381 / JCM 1539 / NBRC 10279 / NRRL Y-324)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT A5DQN2 research and analysis (ICN3D with VR)

FASTA sequences

>sp|A5DQN2|SET5_PICGU Potential protein lysine methyltransferase SET5 OS=Meyerozyma guilliermondii (strain ATCC 6260 / CBS 566 / DSM 6381 / JCM 1539 / NBRC 10279 / NRRL Y-324) OX=294746 GN=SET5 PE=3 SV=2 MIDKLDGQQEPKVEILDINDHVQESSDPVVPHERQIIDDIIAIWKEDPSSESLGVPKLHAKVKSRHPTWSVSEKRVRTLLKTYGLITTNQQFTYANEIHSRIVSSIELPPKVKVTMTAKRGKGLYAKTQIRKGDLIWEERPLFFVPALANVKLVRTGRACAYCAKLLTQRSSTGLSALRGLDCNVCPELWCSKDCKTLDTLHAKLKHNMSSHSNGKGSNLIDASGFIALEDYCFQEQWNALYAITLIYAEMQADKTRTKAEYFSSMARVSQKVRYKAINSSAGSFDTMQGGALFVMEQQEALWNEGYQKFLKVFPSAHDQVPFEEFMMMMGTYNINNLDSCIFLTQSHLNHSCHPNTDVQASTASRTGPLKVFAARDIKAGEELTTSYVNPSHTLHQRQRELRVNWGFICSCQRCKDEAKEHHRRKSSNGMGAKEVPSNIREMLKDTKSAIGNSEIELEIPTVQGGERRKSVRFDEHVISVNQ